Clinical trial
Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark
NCT02066805 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Estimation of Off-Label Use of XGEVA® (Denosumab) Using Population-Based Databases in Denmark
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2014
- Completion date
- February 28, 2015
- Enrollment
- 142 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
xgeva off-label use